| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 |
| filingDate |
2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a6cd3f875aa42ce93c615328b837de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fbd332008899d564e9afbf09135c8e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_408dfbe0b3dad8b271e895494ca3d6aa |
| publicationDate |
2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
LT-5475-B |
| titleOfInvention |
USE OF 2,5-DIHydroxybenzenesulphonic compounds for treating disorders and / or regulating dysfunction of EDHF \ t |
| abstract |
The present invention relates to the use of 2,5-dihydroxybenzenesulfonic compounds in the manufacture of a medicament for regulating the synthesis of nitric oxide (NO) and / or the regulation of endHF (endothelial hyperpolarizing factor) in endothelium of diabetic patients, wherein the medicament is for use in the administration of formula 2.5- daily dose of dihydroxybenzenesulfonic compounds below 500 mg. |
| priorityDate |
2006-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |